Sanofi (SNY) Invested Capital (2009 - 2026)

Sanofi has disclosed Invested Capital across 18 years of filings, most recently posting $106.1 billion for Q2 2026.

• In Q2 2026, Invested Capital rose 3.2% year-over-year to $106.1 billion; the TTM figure through Jun 2026 stood at $106.1 billion (up 3.2% YoY), while the FY2025 annual figure was $105.1 billion, up 3.47% from the prior year.
• Invested Capital came in at $106.1 billion for Q2 2026 at Sanofi, up from $105.1 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $106.1 billion in Q2 2026 to a low of $96.1 billion in Q4 2022.
• Average Invested Capital over 5 years is $100.7 billion, with a median of $100.3 billion recorded in 2024.
• Year-over-year, Invested Capital fell 5.98% in 2022 and grew 4.8% in 2025.
• Over 5 years, Invested Capital stood at $96.1 billion in 2022, then gained by 1.61% to $97.6 billion in 2023, then grew by 2.72% to $100.3 billion in 2024, then grew by 4.8% to $105.1 billion in 2025, then climbed by 0.89% to $106.1 billion in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were $106.1 billion in Q2 2026, $105.1 billion in Q4 2025, and $102.8 billion in Q2 2025.